Best China Stocks To Buy Right Now

 We've spent a lot of time discussing Steve's big stock market calls of late…   And for good reason… He has been on an absolute tear.   Across his three publications – True Wealth, True Wealth Systems, and True Wealth China Opportunities – readers are currently up double digits or better on most of his broad market recommendations in the U.S., Europe, China, and Japan, among others.   But make no mistake… Steve has continued to find big, contrarian opportunities for his subscribers across the investment world.   For example, in early 2016, Steve alerted subscribers to a huge opportunity in an area of the market most investors had left for dead: the resource sector.   At the time, most commodities were in a brutal bear market. Prices had plunged for nearly five straight years… Most resource stocks had lost 75% of their value or more.

Best China Stocks To Buy Right Now: Clean Diesel Technologies Inc.(CDTI)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Here are some of the media stories that may have impacted Accern Sentiment’s analysis:

    Get Molecular Templates alerts:

    Trading Center: Watching the Levels for Molecular Templates, Inc. (:MTEM): Move of 0.02 Since the Open (stocknewscaller.com) Molecular Templates (MTEM) Announces Clinical Data at 2018 ASCO Meeting (streetinsider.com) Gallbladder Cancer Treatment Sales Market Size by Players, Regions, Type, Application and Forecast to 2025 (exclusivereportage.com) ATR in spotlight EnSync, Inc. (NYSE:ESNC), CDTi Advanced Materials, Inc. (NASDAQ:CDTI), Molecular Templates, Inc … (stocksnewspoint.com)

    MTEM has been the subject of several research analyst reports. ValuEngine lowered shares of Molecular Templates from a “hold” rating to a “sell” rating in a research report on Thursday, March 1st. Zacks Investment Research raised shares of Molecular Templates from a “sell” rating to a “hold” rating in a research report on Thursday, June 7th. Four analysts have rated the stock with a hold rating and one has given a buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $5.20.

Best China Stocks To Buy Right Now: Renesola Ltd.(SOL)

Advisors’ Opinion:

  • [By Joseph Griffin]

    These are some of the media headlines that may have impacted Accern’s scoring:

    Get ReneSola alerts:

    ReneSola Sells North Carolina Solar Project To Greenbacker (solarindustrymag.com) ReneSola (SOL) Rating Increased to Neutral at Roth Capital (americanbankingnews.com) ReneSola (SOL) Q1 Earnings in Line, Revenues Top Estimates (zacks.com) ReneSola’s (SOL) CEO Xianshou Li on Q1 2018 Results – Earnings Call Transcript (seekingalpha.com) ReneSola (SOL) Releases Earnings Results (americanbankingnews.com)

    Shares of ReneSola traded up $0.08, hitting $2.76, during trading on Friday, Marketbeat.com reports. The stock had a trading volume of 124,969 shares, compared to its average volume of 108,565. The firm has a market capitalization of $102.11 million, a PE ratio of 21.23 and a beta of 2.05. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.36. ReneSola has a 12 month low of $2.12 and a 12 month high of $3.79.

Best China Stocks To Buy Right Now: Top Image Systems Ltd.(TISA)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Top Image Systems (TISA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best China Stocks To Buy Right Now: Netease.com Inc.(NTES)

Advisors’ Opinion:

  • [By Lisa Levin]

    NetEase, Inc. (NASDAQ: NTES) is expected to post quarterly earnings at $2.19 per share on revenue of $2.18 billion.

    China Distance Education Holdings Limited (NYSE: DL) is estimated to post earnings for its second quarter.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Jounce Therapeutics, Inc. (NASDAQ: JNCE) fell 32.5 percent to $11.92 in pre-market trading. Jounce Therapeutics reported that data from ongoing ICONIC trial of JTX-2011 will be presented at the ASCO.
    Acxiom Corporation (NASDAQ: ACXM) fell 10.7 percent to $24.60 in pre-market trading. Acxiom reported stronger-than-expected results for its fourth quarter, but issued weak FY19 guidance.
    American Public Education, Inc. (NASDAQ: APEI) shares fell 10.7 percent to $35 in pre-market trading.
    Enduro Royalty Trust (NYSE: NDRO) shares fell 8.5 percent to $3.25 in pre-market trading after tumbling 10.76 percent on Wednesday.
    NetEase, Inc. (NASDAQ: NTES) fell 8.3 percent to $244.00 in pre-market trading after reporting Q1 results.
    Aircastle Limited (NYSE: AYR) fell 7.2 percent to $21.30 in pre-market trading after announcing 7.9 million secondary offering of common shares.
    Boxlight Corporation (NASDAQ: BOXL) shares fell 5.6 percent to $9.29 in pre-market trading after rising 2.29percent on Wednesday.
    Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) shares fell 5.3 percent to $3.93 in pre-market trading after rising 5.60 percent on Wednesday.
    Cisco Systems, Inc. (NASDAQ: CSCO) fell 4 percent to $43.40 in pre-market trading. Cisco reported better-than-expected results for its third quarter. The company sees fourth quarter earnings in the range of 68 cents-70 cents with sales growth of 4-6 percent.
    Jack in the Box Inc. (NASDAQ: JACK) fell 3.2 percent to $88.45 in pre-market trading after the company reported downbeat results for its second quarter. Comps were down 0.1 percent in the quarter. The company sees third-quarter comps coming in flat to up 1 percent.
    Children's Place, Inc. (

  • [By Dan Caplinger]

    Investors in NetEase (NASDAQ:NTES) have generally seen their company benefit from a strong environment in the Chinese video game industry. Impressive growth in revenue and profits in past years helped fuel impressive gains for NetEase shares, and the appetite for more from consumers in China and elsewhere has seemed insatiable. Yet in every growth stock’s experience, a company eventually starts to face challenges in sustaining growth, and the key question becomes what that company does to restart its growth engines.

  • [By Dan Caplinger]

    Thursday was a relatively quiet day on Wall Street, and action in different parts of the market showed mixed signals for investors. On one hand, small-cap stocks moved higher, with key benchmarks in that area hitting record highs. Yet the better-known large-cap stock indexes like the S&P 500 gave up early gains. Looking more closely at individual stocks, some companies suffered from bad news that sent their shares falling. J.C. Penney (NYSE:JCP), NetEase (NASDAQ:NTES), and Jounce Therapeutics (NASDAQ:JNCE) were among the worst performers on the day. Here’s why they did so poorly.

  • [By Paul Ausick]

    NetEase Inc. (NASDAQ: NTES) fell by about 9.7% Thursday to post a new 52-week low of $240.08 after closing at $266.00 on Wednesday. The 52-week high is $377.64. Volume of about 4.4 million was more than 4 times the daily average of about 1 million. The reported a profit that missed expectations last night.

  • [By WWW.GURUFOCUS.COM]

    For the details of Overlook Holdings Ltd’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Overlook+Holdings+Ltd

    These are the top 5 holdings of Overlook Holdings LtdNetEase Inc (NTES) – 756,622 shares, 58.02% of the total portfolio. Shares reduced by 15.29%Baidu Inc (BIDU) – 569,283 shares, 41.98% of the total portfolio.

Leave a Reply

Your email address will not be published. Required fields are marked *